I942 EPAC1 agonist

WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 562162

CAS#: 868145-09-9

Description: I942 EPAC1 agonist, also known as I942, is a first in class, isoform selective non-cyclic nucleotide (NCN) EPAC1 agonist.

Price and Availability

Pricing updated 2021-01-21. Prices are subject to change without notice.

I942 EPAC1 agonist is not in stock, may be available through custom synthesis. For cost-effective reason, minimum 1 gram order is requested. The product will be characterized by NMR, HPLC and MS analysis. Purity (HPLC) is usually >98%. CoA, QC data, MSDS will be provided when product is successfully made. The estimated lead time is 2-3 months. Please send email to sales@medkoo.com to inquire quote.

Chemical Structure

Theoretical Analysis

MedKoo Cat#: 562162
Name: I942 EPAC1 agonist
CAS#: 868145-09-9
Chemical Formula: C20H19NO4S
Exact Mass: 369.1035
Molecular Weight: 369.43
Elemental Analysis: C, 65.02; H, 5.18; N, 3.79; O, 17.32; S, 8.68

Synonym: I942; I-942; I 942; I942 EPAC1 agonist

IUPAC/Chemical Name: N-((2,4-Dimethylphenyl)sulfonyl)-2-(naphthalen-2-yloxy)acetamide

InChi Key: KCRXXSQZEZOCFM-UHFFFAOYSA-N

InChi Code: InChI=1S/C20H19NO4S/c1-14-7-10-19(15(2)11-14)26(23,24)21-20(22)13-25-18-9-8-16-5-3-4-6-17(16)12-18/h3-12H,13H2,1-2H3,(H,21,22)

SMILES Code: O=C(NS(=O)(C1=CC=C(C)C=C1C)=O)COC2=CC=C3C=CC=CC3=C2

Technical Data

Appearance:

Solid powder

Purity:

>98% (or refer to the Certificate of Analysis)

Shipping Condition:

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility:

Soluble in DMSO

Shelf Life:

>2 years if stored properly

Drug Formulation:

This drug may be formulated in DMSO

Stock Solution Storage:

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code:

2934.99.9001

References

1: Barker G, Parnell E, van Basten B, Buist H, Adams DR, Yarwood SJ. The Potential of a Novel Class of EPAC-Selective Agonists to Combat Cardiovascular Inflammation. J Cardiovasc Dev Dis. 2017 Dec 5;4(4). pii: E22. doi: 10.3390/jcdd4040022. Review. PubMed PMID: 29367551; PubMed Central PMCID: PMC5753123.

2: Parnell E, McElroy SP, Wiejak J, Baillie GL, Porter A, Adams DR, Rehmann H, Smith BO, Yarwood SJ. Identification of a Novel, Small Molecule Partial Agonist for the Cyclic AMP Sensor, EPAC1. Sci Rep. 2017 Mar 22;7(1):294. doi: 10.1038/s41598-017-00455-7. PubMed PMID: 28331191; PubMed Central PMCID: PMC5428521.

3: Roland M, Everington S. Tackling the crisis in general practice. BMJ. 2016 Feb 17;352:i942. doi: 10.1136/bmj.i942. PubMed PMID: 26887896.

All Products

Featured Products

Newest Products

Research Areas